Texas AG Paxton Sues Tylenol Makers Over Alleged Pregnancy Risk Concealment

Texas Attorney General Ken Paxton has filed a lawsuit against Johnson & Johnson and its spin-off company Kenvue, accusing them of deceptively marketing Tylenol as safe for pregnant women despite alleged known risks of autism and ADHD in children linked to prenatal acetaminophen exposure. This legal action follows President Donald Trump's public statements warning of a connection between Tylenol use during pregnancy and developmental disorders, although medical experts and agencies like the FDA state the evidence remains inconclusive and caution against causing public fear that could harm maternal care. Paxton alleges that Johnson & Johnson tried to evade liability by transferring responsibilities to Kenvue and accuses Big Pharma of prioritizing profits over public health. Johnson & Johnson's Kenvue division denies these claims, emphasizing the safety of acetaminophen as supported by global medical consensus and pledging to contest the lawsuit. The controversy has stirred a debate between public officials pushing for accountability and the medical community urging adherence to scientific evidence to avoid misinformation. The case reflects broader tensions over pharmaceutical accountability and the communication of drug safety during pregnancy.